Clinical Trial Update: Effect of Rosiglitazone on the Vascular Biology of Human Fat Tissue [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating rosiglitazone’s effects on vascular biology in human fat tissue has completed and results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Insulin Resistance
• Metabolic Syndrome

Drugs mentioned

• Rosiglitazone (rosiglitazone)

Snippet

Sponsor: University of Massachusetts, Worcester | Conditions: Metabolic Syndrome, Insulin Resistance | Phase 2 | Status: COMPLETED | Results posted: 2012-03-26